No Data
No Data
Kintara Therapeutics Announces Upcoming Merger With TuHURA Biosciences
Kintara Therapeutics Q3 2024 GAAP EPS $(0.05)
Kintara Therapeutics (NASDAQ:KTRA) reported quarterly losses of $(0.05) per share.
10-Q: Quarterly report
Press Release: Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results
Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results PR Newswire SAN DIEGO, May 14, 2024 SAN DIEGO, May 14, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Ki
Kintara Therapeutics 3Q Loss/Shr 5c >KTRA
Kintara Therapeutics 3Q Loss/Shr 5c >KTRA
Why Alphabet Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Shares of Alphabet Inc. (NASDAQ:GOOGL) (NASDAQ:GOOG) rose sharply in today's pre-market trading the company posted upbeat results for its first quarter.Google parent Alphabet said its first-quarter re
No Data